Trial intelligence / Profile preview

Vascugel (SRM003) for AVF maturation in hemodialysis patients

NCT01806545Phase 2Completed

Sponsor
Takeda
Start
Mar 2013
Primary completion
Oct 2014
Countries
1
01

Overview

A Phase 2 trial of Vascugel in arteriovenous fistula (AVF), sponsored by Takeda. Started Mar 2013; status: completed.

02

Drugs

Vascugel
03

Conditions

arteriovenous fistula (AVF)

Beyond the preview

Go deeper on NCT01806545.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01806545.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call